Top High Tech Stocks To Own For 2018


Investment company Carl Icahn buys Welbilt Inc, sells Federal-Mogul Holdings Corp, Nuance Communications Inc, Allergan PLC during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Icahn Capital Management LP. As of 2017-03-31, Icahn Capital Management LP owns 16 stocks with a total value of $19.9 billion. These are the details of the buys and sells.

New Purchases: WBT, Added Positions: IEP, HLF, NAV, Reduced Positions: PYPL, Sold Out: FDML, NUAN, AGN,


For the details of Carl Icahn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) – 140,524,155 shares, 36.12% of the total portfolio. Shares added by 8.10%American International Group Inc (AIG) – 45,644,982 shares, 14.29% of the total portfolio. Cheniere Energy Inc (LNG) – 32,680,490 shares, 7.75% of the total portfolio. CVR Energy Inc (CVI) – 71,198,718 shares, 7.17% of the total portfolio. PayPal Holdings Inc (PYPL) – 31,574,653 shares, 6.81% of the total portfolio. Shares reduced by 5.46%New Purchase: Welbilt Inc (WBT)


Carl Icahn initiated holdings in Welbilt Inc. The purchase prices were between $18.25 and $19.75, with an estimated average price of $19.15. The stock is now traded at around $18.89. The impact to the portfolio due to this purchase was 1.04%. The holdings were 10,582,660 shares as of 2017-03-31.

Top High Tech Stocks To Own For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):


    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Top High Tech Stocks To Own For 2018: Christopher & Banks Corporation(CBK)


Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Christopher & Banks Corporation (NYSE: CBK) got a boost, shooting up 24 percent to $1.50 after the company reported strong preliminary revenue for the third quarter.

  • [By Lisa Levin]

    Christopher & Banks Corporation (NYSE: CBK) shares were also up, gaining 40 percent to $2.64. Christopher & Banks reported a Q4 loss of $0.24 per share on revenue of $94.6 million. The company projects Q1 revenue of $93 million to $98 million.

Top High Tech Stocks To Own For 2018: Energy XXI Ltd. (EXXIQ)


Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The reality is often different. What is going on with Bellatrix Exploration is actually above average. I have written about many companies such as Sandridge Energy (NYSE:SD), Energy XXI (OTCPK:EXXIQ), and Halcon Resources (NYSE:HK) where the companies supposedly has premier assets, fantastically valuable reserves, and the investors lost everything. Right now Chesapeake Energy (NYSE:CHK) appears to be heading down the same miserable pathway as the others. At least with Bellatrix, the company appears to be entering the slow turnaround phase. But this has definitely not been a painless experience.

Top High Tech Stocks To Own For 2018: Atara Biotherapeutics, Inc.(ATRA)

Advisors’ Opinion:

  • [By Chris Lange]

    Atara Biotherapeutics Inc. (NASDAQ: ATRA) shares surged on Friday after the firm announced that it received clearance from the U.S. Food and Drug Administration (FDA) to initiate two Phase 3 clinical studies. Specifically these mid-stage studies deal with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+PTLD).

Leave a Reply

Your email address will not be published. Required fields are marked *